Blog
- News/
Exazyme partners with Ginkgo Bioworks and becomes part of the Ginkgo Technology Network
Exazyme partners with Ginkgo Bioworks, joining the Ginkgo Technology Network to empower R&D teams with AI-driven protein engineering solutions.
Read More
- News/
Optimized Molecules: A Berlin-based startup uses Artificial Intelligence to enhance the effectiveness of enzymes.
Exazyme shares their vision on optimizing proteins, from enzymes to anti-bodies. Embark on our latest projects and next steps.
Read More
- News/
Biochemical stars meet Artificial Intelligence: The startup Exazyme uses machine learning to develop blueprints for new enzymes.
Exazyme, initially started as an EXIST Gründerstipendium and Spin-Off from Freie Universität Berlin, has now successfully raised their first VC-investment.
Read More
- News/
Faces of Future: Dr. Ingmar Schuster
Ingmar Schuster, Exazyme CEO, pioneers AI-driven protein development at Startup Villa, revolutionizing industries for sustainability and efficiency.
Read More
- News/
Funding for AI-supported protein development: Berlin-based startup Exazyme secures €2 million from AIX Ventures and Atlantic Labs.
Richard Socher, AI expert and AIX Ventures founding partner, anticipates top-tier solutions with Exazyme’s blend of expertise and advanced algorithms.
Read More
- News/
DealMonitor: 468 invests in Gauss Robotics – Exazyme secures €2 million – D2C Angels bet on ingarden
Exazyme, Berlin-based AI-Biotech startup, secures €2M Series A funding from AIX Ventures & Atlantic Labs. Discover how we revolutionize Protein Design.
Read More